Member Info for EmeraldCarrots

Trades going through @ 0.33p and still in auction.

All IMHO.

About time.

Up 25% ish then??

Big ones.

Do worse than they have? I find it incomprehensible. The new CEO needs to sort things out. Parsortix is a proven machine. Probably the best machine for catching CTC's in the entire World. Not only that they are 99% live, intact, uncontaminated and perfect for DNA analysis. Something that Myriad Genetics are looking at right now. How on Earth is it possible for Angle to fail to make a profit? It is incomprehensible. The new CEO has a very good chance of turning this around IMHO. Just look at the facts of what they have.

All IMHO.

Recently. One of the totally stunning and incomprehensible business oppertunities Angle have seemingly been unable to capitalise on.

Forward. "The initial emphasis will be on the proteomics and genomics market segment. Here the Company will seek to maximise the potential of its proprietary Parsortix platform for CTC isolation by developing applications that integrate existing proteomics and genomic assays capable of providing complementary insights to circulating tumour DNA.".

So, as I read it, they are looking to help expand existing DNA testing of tumour tissue etc. with the DNA testing of the circulating tumor cells (CTC's). This focuses on what is almost unique about parsortix. It's ability to catch live, intact, uncontaminated CTC's that are therefore perfect for DNA analysis.

All IMHO.

https://www.lse.co.uk/rns/AGL/strategy-update-rs8ksqq77706yyk.html

Market was not already aware of so the 20% sp drop is unjustified IMHO.

Quite how Mr Newland managed to get the Company in this situation is quite unbelievable. Litrally unbelievable. I honestly think he has something wrong with him.

All IMHO.

8.51%

Up 4.26% now.

It's a miracle.

Up 1%

Every little helps.

NOT contacted Genedrive. They have the alternative machine that unfortunately needs a fridge to keep the reagents cold.

https://www.nice.org.uk/guidance/dg59/chapter/1-Recommendations

Point-of-care testing

1.4 Use the Genedrive CYP2C19 ID Kit point-of-care test for CYP2C19 genotype testing when laboratory-based testing is not available.

1.5 Use the Genomadix Cube point-of-care test when laboratory-based testing and the Genedrive CYP2C19 ID Kit point-of-care test are not available.

JIMMYCALDERWOOD.

"Property background rather than this sector ?".

=========================

Looks that way. He obviously views Genedrive as an investment and wants a seat on the board for his input.

David Nugent:-

https://find-and-update.company-information.service.gov.uk/company/05104042/officers

https://find-and-update.company-information.service.gov.uk/company/03655985

The RNS of 29th August 2025 (about 6 weeks ago) is progressing well. It seems to me highly unlikely Myriad would have taken this step without a reasonable chance of success. Also other Companies similar to Myriad would have taken note.

https://www.lse.co.uk/rns/AGL/angle-announces-collaboration-with-myriad-genetics-4kpdj9qi4z8069w.html

The RNS of 29th August 2025 (about 6 weeks ago) is progressing well. It seems to me highly unlikely Myriad would have taken this step without a reasonable chance of success. Also other Companies similar to Myriad would have taken note.

https://www.lse.co.uk/rns/AGL/angle-announces-collaboration-with-myriad-genetics-4kpdj9qi4z8069w.htmlMyriad Genetics.

He risks losing all his investment, or does he? The earlier RNS says "The Company's cash runway has recently been extended through to the end of 2025 as a result of the Firm Placing completing". That was the 400,000,000 additional shares in the "first placing" so to speak. So about 3 months money. At what point, assuming a "no" vote do the board "throw in the towel"? 6 weeks before the cach runs out? 4 weeks? Has Mr Nugent got the money to make a bid? Loads of questions...............

Food for thought.

======================

That aside Genedrive needs sales. You know, when a hospital places an order, the machine(s) are installed and the initial invoice is sent out. So what is happeneing with the Scottish rollout (15 hospitals worth?). When are the last five English hospitals going to get the MT-RNR1 bringing the total to 14? When is the first cardiac ward to get the first Genedrive CYP2C19-ID Kit??

***WHAT IS THE NEWS ON ALL THIS??*** FFS!

All IMHO.

USA investiors would have got involved and we would no be in this situation. That is fact IMHO.

If it can't be done soon then offer a license deal to an existing USA player.

FDA approval for the MT-RNR1 would be worth tens of millions of $.

All IMHO.

Some ideas for improving things.

1. The company only needs minimum sales staff for the UK. The UK NHS market is almost totally controlled by NHS England and NICE. NICE commitees are so clever they believe a lab test is the first choice. Even when that test takes hours and sometimes days when the result is needed within an hour! Quite how these super smart people on these commitees work that one out beggars belief.

2. Slash the directors wages.

3. New International sales Director needed to plan and implement sales to the European Union. Someone with experience of selling medical equipment to hopsitals in the EU.

4. MT-RNR1. Find a way to get the FDA application done before xmass. The Company has already had over a year to do this to date. FDIND A WAY!!!

All IMHO.

29%? That would be interesting.